Sonoma Pharmaceuticals (SNOA) Revenue & Revenue Breakdown


OverviewOwnershipFinancialsChart

Sonoma Pharmaceuticals Revenue Highlights


Latest Revenue (Y)

$12.73M

Latest Revenue (Q)

$3.39M

Main Segment (Y)

Human Care

Main Geography (Y)

Service

Sonoma Pharmaceuticals Revenue by Period


Sonoma Pharmaceuticals Revenue by Year

DateRevenueChange
2024-03-31$12.73M-4.05%
2023-03-31$13.27M5.10%
2022-03-31$12.63M-32.21%
2021-03-31$18.63M-1.62%
2020-03-31$18.94M-0.18%
2019-03-31$18.97M13.88%
2018-03-31$16.66M29.89%
2017-03-31$12.82M-14.98%
2016-03-31$15.08M8.88%
2015-03-31$13.85M1.36%
2014-03-31$13.67M-11.55%
2013-03-31$15.45M21.25%
2012-03-31$12.74M30.65%
2011-03-31$9.75M32.46%
2010-03-31$7.36M36.67%
2009-03-31$5.39M40.50%
2008-03-31$3.83M-15.58%
2007-03-31$4.54M75.81%
2006-03-31$2.58M90.56%
2005-03-31$1.36M50.33%
2004-03-31$902.00K-63.48%
2003-03-31$2.47M23.50%
2002-03-31$2.00M-

Sonoma Pharmaceuticals generated $12.73M in revenue during NA 2024, up -4.05% compared to the previous quarter, and up 67.13% compared to the same period a year ago.

Sonoma Pharmaceuticals Revenue by Quarter

DateRevenueChange
2024-06-30$3.39M-1.40%
2024-03-31$3.44M9.59%
2023-12-31$3.14M14.90%
2023-09-30$2.73M-20.31%
2023-06-30$3.43M13.70%
2023-03-31$3.01M2.38%
2022-12-31$2.94M-11.62%
2022-09-30$3.33M-16.37%
2022-06-30$3.98M73.32%
2022-03-31$2.30M-20.81%
2021-12-31$2.90M-22.49%
2021-09-30$3.74M1.63%
2021-06-30$3.68M70.79%
2021-03-31$2.16M-56.30%
2020-12-31$4.94M-14.44%
2020-09-30$5.77M-20.47%
2020-06-30$7.25M58.42%
2020-03-31$4.58M-2.12%
2019-12-31$4.68M-5.84%
2019-09-30$4.97M5.46%
2019-06-30$4.71M7.51%
2019-03-31$4.38M-17.01%
2018-12-31$5.28M6.90%
2018-09-30$4.94M13.05%
2018-06-30$4.37M19.53%
2018-03-31$3.65M-24.53%
2017-12-31$4.84M11.98%
2017-09-30$4.33M12.78%
2017-06-30$3.83M-4.82%
2017-03-31$4.03M19.88%
2016-12-31$3.36M-18.18%
2016-09-30$4.11M7.79%
2016-06-30$3.81M7.96%
2016-03-31$3.53M-7.59%
2015-12-31$3.82M-5.77%
2015-09-30$4.05M10.16%
2015-06-30$3.68M-7.54%
2015-03-31$3.98M23.68%
2014-12-31$3.22M-1.41%
2014-09-30$3.26M-3.77%
2014-06-30$3.39M16.40%
2014-03-31$2.91M-11.51%
2013-12-31$3.29M-19.47%
2013-09-30$4.09M21.26%
2013-06-30$3.37M1.11%
2013-03-31$3.33M-5.79%
2012-12-31$3.54M-21.79%
2012-09-30$4.53M11.73%
2012-06-30$4.05M20.89%
2012-03-31$3.35M20.11%
2011-12-31$2.79M-23.83%
2011-09-30$3.66M24.59%
2011-06-30$2.94M8.45%
2011-03-31$2.71M17.21%
2010-12-31$2.31M-6.20%
2010-09-30$2.47M8.92%
2010-06-30$2.26M1.43%
2010-03-31$2.23M38.38%
2009-12-31$1.61M-3.53%
2009-09-30$1.67M-9.47%
2009-06-30$1.85M25.22%
2009-03-31$1.48M20.80%
2008-12-31$1.22M-17.56%
2008-09-30$1.48M22.30%
2008-06-30$1.21M30.78%
2008-03-31$926.00K-13.13%
2007-12-31$1.07M-

Sonoma Pharmaceuticals generated $3.39M in revenue during Q1 2025, up -1.40% compared to the previous quarter, and up 112.51% compared to the same period a year ago.

Sonoma Pharmaceuticals Revenue Breakdown


Sonoma Pharmaceuticals Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceMar 24Mar 23Mar 22Mar 21Mar 20
Service And Royalty$422.00K----
Animal Care$2.20M----
Human Care$10.11M----
Shipping and Handling-$42.00K$52.00K$37.00K-
Service--$349.00K$112.00K-
Product----$15.69M

Sonoma Pharmaceuticals's latest annual revenue breakdown by segment (product or service), as of Mar 24: Human Care (79.39%), Animal Care (17.30%), and Service And Royalty (3.31%).

Quarterly Revenue by Product

Product/ServiceSep 24Mar 24Dec 23Sep 23Jun 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Dec 20Sep 20Jun 20Mar 20Mar 19
Animal Care$402.00K$1.09M$621.00K$489.00K$414.00K$818.00K$1.00M$812.00K$1.36M$951.00K$377.00K------
Human Care$2.96M$5.57M$2.46M$2.08M$1.81M$2.02M$2.59M$2.71M$3.53M$4.78M$6.86M------
Service And Royalty$220.00K$199.00K$56.00K$167.00K$69.00K$148.00K$157.00K----------
Service----$99.00K$75.00K$147.00K$1.03M$280.00K--------
Other Sales------------$45.00K$42.00K$13.00K--
Product----------------$4.11M

Sonoma Pharmaceuticals's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Human Care (82.62%), Animal Care (11.23%), and Service And Royalty (6.15%).

Sonoma Pharmaceuticals Revenue Breakdown by Country

Annual Revenue by Country

CountryMar 22
Shipping and Handling$52.00K
Service$349.00K

Sonoma Pharmaceuticals's latest annual revenue breakdown by geography, as of Mar 22: Service (87.03%), and Shipping and Handling (12.97%).

Quarterly Revenue by Country

CountryDec 20Sep 20Jun 20
Europe and Rest of the World$1.65M$1.76M$3.21M
UNITED STATES$1.98M$1.98M$1.72M
Latin America$1.31M$2.02M$2.32M

Sonoma Pharmaceuticals's latest quarterly revenue breakdown by geography, as of Dec 20: UNITED STATES (40.07%), Europe and Rest of the World (33.45%), and Latin America (26.48%).

Sonoma Pharmaceuticals Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
PTPIPetros Pharmaceuticals$5.82B$1.42M
LFCRLifecore Biomedical$128.26M$24.70M
ACORAcorda Therapeutics$102.42M$20.29M
ALIMAlimera Sciences$80.75M$23.01M
DERMJourney Medical$79.18M$14.86M
SBFMSunshine Biopharma$39.85M$9.30M
TKNOAlpha Teknova$36.68M$9.58M
UPCUniverse Pharmaceuticals$32.31M$13.84M
SNOASonoma Pharmaceuticals$12.73M$3.39M
GHSIGuardion Health Sciences$12.25M$36.35K
AKANAkanda$2.16M$762.61K
SXTCChina SXT Pharmaceuticals$1.97M$939.58K
SHPHShuttle Pharmaceuticals--

SNOA Revenue FAQ


What is Sonoma Pharmaceuticals’s yearly revenue?

Sonoma Pharmaceuticals's yearly revenue for 2024 was $12.74M, representing a decrease of -4.05% compared to 2023. The company's yearly revenue for 2023 was $13.27M, representing an increase of 5.10% compared to 2022. SNOA's yearly revenue for 2022 was $12.63M, representing a decrease of -32.21% compared to 2021.

What is Sonoma Pharmaceuticals’s quarterly revenue?

Sonoma Pharmaceuticals's quarterly revenue for Q1 2025 was $3.39M, a -1.40% decrease from the previous quarter (Q4 2024), and a -1.05% decrease year-over-year (Q1 2024). The company's quarterly revenue for Q4 2024 was $3.44M, a 9.59% increase from the previous quarter (Q3 2024), and a 14.10% increase year-over-year (Q4 2023). SNOA's quarterly revenue for Q3 2024 was $3.14M, a 14.90% increase from the previous quarter (Q2 2024), and a 6.59% increase year-over-year (Q3 2023).

What is Sonoma Pharmaceuticals’s revenue growth rate?

Sonoma Pharmaceuticals's revenue growth rate for the last 3 years (2022-2024) was 0.85%, and for the last 5 years (2020-2024) was -32.75%.

What are Sonoma Pharmaceuticals’s revenue streams?

Sonoma Pharmaceuticals's revenue streams in r 24 are Service And Royalty, Animal Care, and Human Care. Service And Royalty generated $422K in revenue, accounting 3.31% of the company's total revenue Animal Care generated $2.2M in revenue, accounting 17.30% of the company's total revenue Human Care generated $10.11M in revenue, accounting 79.39% of the company's total revenue

What is Sonoma Pharmaceuticals’s main source of revenue?

For the fiscal year ending Mar 24, the largest source of revenue of Sonoma Pharmaceuticals was Human Care. This segment made a revenue of $10.11M, representing 79.39% of the company's total revenue.